Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Nanomedicine conference to discuss the changing practice of healthcare and challenges in integrating nanotech into established business models

Abstract:
The Institute of Nanotechnology, global leader in nanotechnology information services, is organising its second annual nanomedicine conference and exhibition which will showcase the latest developments in medical nanotechnologies and potential routes to finance. The two day event will see leading multinational companies, such as Philips, AstraZeneca, GE Healthcare, GlaxoSmithKline, Volcano Corporation and Fresenius Medical Care, sharing their vision of the impacts of nanomedicine on healthcare and providing a window on their activities.

Nanomedicine conference to discuss the changing practice of healthcare and challenges in integrating nanotech into established business models

London, UK | Posted on November 20th, 2007

Key discussions will be on the changing practice of healthcare, challenges in integrating nanomedicine into established business models, managing ‘risks and uncertainties' , the role of public-private partnerships in building value, requirements for better regulation and standardisation as well as the barriers to the clinic. The conference will also have three main technology sessions, 'Drug Delivery and Pharmaceutical Development', ‘Tissue Engineering and Regenerative Medicine' and 'Novel Devices, Nanosensors, Diagnostics and Imaging'.

The Head of ‘Nanosciences and Nanotechnologies' unit at The European Commission will outline the EC's nanomedicine plan and how some of the €800million dedicated under FP7 will be targeted towards new nanotechnology-based treatments. The Wellcome Trust will present details about their funding priorities and new technology transfer initiatives and EMEA will summarise their views on regulatory hurdles. The conference will also see a number of innovative small companies' presenting novel nanomedical technologies and presentations from top scientists as far away as India and Malaysia. The associated exhibition will showcase new innovations in nanomedicine and provide a unique opportunity to network with potential partners.

Investing in Medical Nanotechnology II builds upon the success of the inaugural event held last year to bring the latest developments in the exciting and dynamic new field of nanomedicine. The event sponsored by Marks & Clerk, MTI Partners and Tinytech Jobs will take place on 28-29 November at the historic and prestigious Royal College of Surgeons in London. Further details are available at http://nanomednet.org/conference07/ or alternatively contact Tiju Joseph at the Institute of Nanotechnology on +44 (0) 141 330 8734.

####

For more information, please click here

Contacts:
Tiju Joseph

+44 (0) 141 330 8734

Copyright © Institute of Nanotechnology

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Implantable 'living pharmacy' could control body's sleep/wake cycles: Project receives DARPA contract worth up to $33 million over 4 1/2 years May 13th, 2021

Tiny, Wireless, Injectable Chips Use Ultrasound to Monitor Body Processes May 12th, 2021

World's first fiber-optic ultrasonic imaging probe for future nanoscale disease diagnostics April 30th, 2021

Arrowhead Announces Improvement in Fibrosis after ARO-AAT Treatment in Patients with Alpha-1 Liver Disease April 28th, 2021

Announcements

Emergence of a new heteronanostructure library May 14th, 2021

Nanophotonics enhanced coverslip for phase imaging in biology May 14th, 2021

New technology enables rapid sequencing of entire genomes of plant pathogens May 14th, 2021

Harvesting light like nature does:Synthesizing a new class of bio-inspired, light-capturing nanomaterials May 14th, 2021

Events/Classes

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

CEA-Leti Envisions Widespread Use of LiDAR Systems Based on Integrated Optical Phased Arrays (OPAs): OPAs with Solid-State Beam Steering Can Reduce the Cost and Size of LiDAR Systems & Improve Performance; Results Reported at Photonics West 2021 March 9th, 2021

CEA-Leti Announces 16 Papers to Be Presented At Photonics West 2021 and a Virtual Workshop on March 25 March 3rd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project